Product Synopsis:
The Future of the Prepared Meals Market in Hong Kong to 2017 is the result of Canadean's extensive market research. The report presents detailed analysis on the Prepared Meals consumption trends in Hong Kong, historic and forecast Prepared Meals consumption volumes and values at market and category level, brand share and distribution channel data.
https://www.reportscorner.com/reports/14966/The-Future-of-the-Prepared-Meals-Market-in-Hong-Kong-to-2017/
Therapeutic class overview treating refractory hematological malignancies - R...Reports Corner
The document discusses innovative drug development strategies for treating refractory hematological malignancies. Over the past decade, proteasome inhibitors and immunomodulatory drugs have improved treatment outcomes for multiple myeloma patients. However, patients eventually relapse, highlighting the need for new treatment options for relapsed or refractory multiple myeloma. Two new drugs, pomalidomide and carfilzomib, have addressed this need but room for additional therapies remains. The report provides an overview of approved therapies and unmet needs in treating relapsed myeloma, acute myeloid leukemia, and myelodysplastic syndromes as well as a discussion of promising late-stage drug pipelines and commercial opportunities in these therapeutic areas.
Wireless security companies and solutions 2014 - ReportsCornerReports Corner
Overview:
Collectively speaking, wireless security represents technologies and solutions designed to prevent unauthorized access or information damage for computers connected to wireless networks.
https://www.reportscorner.com/reports/37807/Wireless-Security-Companies-and-Solutions-2014/
The cybersecurity market in nigeria to 2023 market brief - Reports Corner
Synopsis
SDI's "The Cybersecurity Market in Nigeria to 2023: Market Brief" provides a top-level, category specific view of the forecast market value of Cybersecurity expenditure in Nigeria.
Summary
SDI's "The Cybersecurity Market in Nigeria to 2023: Market Brief", provides a top-level, quantitative view of forecast expenditure of Cybersecurity sector in Nigeria. - Reports Corner
https://www.reportscorner.com/reports/27313/The-Cybersecurity-Market-in-Nigeria-to-2023:-Market-Brief/
The global military rotorcraft market 2013 2023 - Reports CornerReports Corner
Product Synopsis
This report is the result of SDI's extensive market and company research covering the global rotorcraft industry. It provides detailed analysis of both historic and forecast global industry values, factors influencing demand, the challenges faced by industry participants, analysis of the leading companies in the industry, and key news.
https://www.reportscorner.com/reports/27221/The-Global-Military-Rotorcraft-Market--2013-2023/
PSA Peugeot Citroen Automotive Company Profile, SWOT and Financial Report...Reports Corner
Synopsis
ICD Research's "PSA Peugeot Citroen : Automotive - Company Profile, SWOT and Financial Report" contains in depth information and data about the company and its operations.
https://www.reportscorner.com/reports/27219/PSA-Peugeot-Citroen-:-Automotive---Company-Profile,-SWOT-and-Financial-Report/
Renewable energy in germany - Reports CornerReports Corner
Introduction
Renewable Energy in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
https://www.reportscorner.com/reports/26823/Renewable-Energy-in-Germany/
Global Markets Direct's, 'Carcinomas - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Carcinomas, complete with latest updates, and special features on late-stage and discontinued projects.
https://www.reportscorner.com/reports/23246/Carcinomas-%E2%80%93-Pipeline-Review,-H1-2013/
Global Markets Direct's, 'Esophageal Cancer - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Esophageal Cancer, complete with latest updates, and special features on late-stage and discontinued projects.
https://www.reportscorner.com/reports/23243/Esophageal-Cancer-%E2%80%93-Pipeline-Review,-H1-2013/
Therapeutic class overview treating refractory hematological malignancies - R...Reports Corner
The document discusses innovative drug development strategies for treating refractory hematological malignancies. Over the past decade, proteasome inhibitors and immunomodulatory drugs have improved treatment outcomes for multiple myeloma patients. However, patients eventually relapse, highlighting the need for new treatment options for relapsed or refractory multiple myeloma. Two new drugs, pomalidomide and carfilzomib, have addressed this need but room for additional therapies remains. The report provides an overview of approved therapies and unmet needs in treating relapsed myeloma, acute myeloid leukemia, and myelodysplastic syndromes as well as a discussion of promising late-stage drug pipelines and commercial opportunities in these therapeutic areas.
Wireless security companies and solutions 2014 - ReportsCornerReports Corner
Overview:
Collectively speaking, wireless security represents technologies and solutions designed to prevent unauthorized access or information damage for computers connected to wireless networks.
https://www.reportscorner.com/reports/37807/Wireless-Security-Companies-and-Solutions-2014/
The cybersecurity market in nigeria to 2023 market brief - Reports Corner
Synopsis
SDI's "The Cybersecurity Market in Nigeria to 2023: Market Brief" provides a top-level, category specific view of the forecast market value of Cybersecurity expenditure in Nigeria.
Summary
SDI's "The Cybersecurity Market in Nigeria to 2023: Market Brief", provides a top-level, quantitative view of forecast expenditure of Cybersecurity sector in Nigeria. - Reports Corner
https://www.reportscorner.com/reports/27313/The-Cybersecurity-Market-in-Nigeria-to-2023:-Market-Brief/
The global military rotorcraft market 2013 2023 - Reports CornerReports Corner
Product Synopsis
This report is the result of SDI's extensive market and company research covering the global rotorcraft industry. It provides detailed analysis of both historic and forecast global industry values, factors influencing demand, the challenges faced by industry participants, analysis of the leading companies in the industry, and key news.
https://www.reportscorner.com/reports/27221/The-Global-Military-Rotorcraft-Market--2013-2023/
PSA Peugeot Citroen Automotive Company Profile, SWOT and Financial Report...Reports Corner
Synopsis
ICD Research's "PSA Peugeot Citroen : Automotive - Company Profile, SWOT and Financial Report" contains in depth information and data about the company and its operations.
https://www.reportscorner.com/reports/27219/PSA-Peugeot-Citroen-:-Automotive---Company-Profile,-SWOT-and-Financial-Report/
Renewable energy in germany - Reports CornerReports Corner
Introduction
Renewable Energy in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
https://www.reportscorner.com/reports/26823/Renewable-Energy-in-Germany/
Global Markets Direct's, 'Carcinomas - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Carcinomas, complete with latest updates, and special features on late-stage and discontinued projects.
https://www.reportscorner.com/reports/23246/Carcinomas-%E2%80%93-Pipeline-Review,-H1-2013/
Global Markets Direct's, 'Esophageal Cancer - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Esophageal Cancer, complete with latest updates, and special features on late-stage and discontinued projects.
https://www.reportscorner.com/reports/23243/Esophageal-Cancer-%E2%80%93-Pipeline-Review,-H1-2013/
Introduction
Textile Mills in India industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and
forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within
the market. Essential resource for top-line data and analysis covering the India textile mills market. Includes market size and segmentation data, textual
and graphical analysis of market growth trends, leading companies and macroeconomic information.
https://www.reportscorner.com/reports/23018/Textile-Mills-in-India/
This document describes 11 reports available for purchase from ReportsCorner.com on topics including ICT spending predictions for industries in Belgium, the chocolate market in Asia-Pacific and BRIC countries, the gum market in BRIC countries, and the sugar confectionery market in BRIC countries. Each report costs $495-$1000 and provides historical and forecast data on consumption trends segmented by brand, channel, category and geography.
Immunoglobulins market to 2019 demand in primary immunodeficiency (pi) and ...Reports Corner
GBI Research's report "Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer's Disease" provides in-depth analysis of the global immunoglobulin market. The report analyzes the markets for immunoglobulin products in the US, the top five European countries (the UK, Germany, France, Italy and Spain) and Japan.
https://www.reportscorner.com/reports/20855/Immunoglobulins-Market-to-2019---Demand-in-Primary-Immunodeficiency-(PI)-and-Chronic-Inflammatory-Demyelinating-Polyneuropathy-(CIDP)-Potentially-Supplemented-by-Approvals-for-Alzheimers-Disease/
Next generation network oss bss market and forecast 2013-2018 - Reports CornerReports Corner
"NGN promises a high quality end-user experience. Telecommunications service providers expect the NGN framework to provide them with tools that would ensure customer loyalty. However, the path towards achieving the ideal NGN is fraught with formidable challenges. The most critical challenge confronting operators is optimizing their OSS and BSS platforms, systems, and processes.
With research beginning in 2007, the report Next Generation Network OSS/BSS Market and Forecast 2013-2018 provides a comprehensive analysis of drivers and issues related to technical and business aspects of OSS/BSS deployments and developments while forecasting their growth over the next five years."
https://www.reportscorner.com/reports/20852/Next-Generation-Network-OSS/BSS-Market-and-Forecast-2013-2018/
The cbrn defense market 2013 2023 - Reports CornerReports Corner
The document provides an overview and analysis of the global CBRN (chemical, biological, radiological, nuclear) defense market from 2013 to 2023. It finds that the market is expected to grow from $9 billion in 2013 to $13.7 billion in 2023, driven by threats from terrorism and hostile countries. North America currently leads the market but Asia-Pacific is expected to see the fastest growth. CBRN protection equipment accounts for the majority of the market currently but detection systems are expected to see increased investment over the forecast period. Key countries and their projected defense spending on CBRN capabilities are also analyzed.
Indian in vitro diagnostics market opportunity analysis 2018 - Reports CornerReports Corner
The Indian in vitro diagnostics (IVD) market is valued at over $500 million in 2018 and is expected to reach $1 billion by 2026, growing at a compound annual growth rate of 19%. This remarkable growth can be attributed to increased healthcare awareness, a desire for preventive health checkups, the availability of disease-specific tests, and a shift from manual to more automated equipment. The market is led by global players and lacks local manufacturers who can develop their own products and technologies. The report analyzes the segments of the Indian IVD market and identifies drivers of growth as well as challenges that must be addressed for continued expansion.
Pharmaceutical market india a comprehensive industry analysis - Reports CornerReports Corner
"1.0 Summary
“Pharmaceutical Market: India, A Competitive Industry Analysis” by Kelly Scientific Publications is a comprehensive report on the pharmaceutical and biotechnology industry in India and its impact on international markets. This report scrutinises top Indian pharmacos and their battle within domestic and international therapeutic markets. The business environment in which they compete is analysed as are key drivers, constraints, challenges and opportunities.
The Indian pharmaceutical market is set to become the eight largest pharma market globally by 2015. In 2012 it was worth $13 billion. It is forecast to reach $50 billion by 2015 and increase its dominance as a leading player in Asia. It is predicted that the Indian pharma market will be a significant global competitor by 2020 with an expected worth of up to $74 billion.
This report describes the current therapeutics that are propelling the biopharmaceutical market in India. It examines the current economic climate and how India compares to other emerging markets and also evolved markets such as the US and Europe. Current developments relating to patent expirations, government funding, and regulations are discussed. The emerging trends that appear in key sub-markets such as generics, oncology, cardiovascular, diabetes and vaccines are elucidated and analysed.
This study reveals market figures of the overall Indian pharmaceutical market and sub-markets. Forecast projections and future growth rates are provided to give the reader a forthcoming perspective of this growing industry.
https://www.reportscorner.com/reports/15826/Pharmaceutical-Market:-India-A-Comprehensive-Industry-Analysis/
Global pharmaceutical & biotechnology outlook 2013 japan pharma - Reports CornerReports Corner
The coming years will see Japan pharma regaining its status as innovator driven with Edoxaban for Daiichi Sankyo, Canagliflozin for Mitsubishi Tanabe, and Dolutegravir for Shionogi bringing the good times back for the respective companies in 2013 and carrying enough potential to change global market dynamics in the anticoagulant, diabetes and HIV space resp. We think that the massive ~$45b poured in acquiring innovation by Japanese companies does not justify its value as we find that the key catalysts from Japan are in-house candidates.
https://www.reportscorner.com/reports/10015/Global-Pharmaceutical-&-Biotechnology-Outlook-2013:-Japan-Pharma/
Global pharmaceutical & biotechnology outlook 2013 rising stars - Reports CornerReports Corner
Innovative and improved drugs therapies developed through novel target discovery and technology platforms have originated from the backyards of small research focused companies (Rising Stars, RS, non-profitable biotech companies). The universe continues to grow despite the high risk and the wait to transform into a successful profitable Mature Biotech is long.
https://www.reportscorner.com/reports/10016/Global-Pharmaceutical-&-Biotechnology-Outlook-2013:-Rising-Stars/
Mobile vas markets, applications, and opportunities third edition - Reports...Reports Corner
Mobile Value-added Service (VAS) applications represent a key aspect to the ongoing success of mobile network operators and everyone in the mobile communications value chain. With core services, such as bear voice and data communications becoming commodity offerings, wireless service providers are dependent on VAS applications to drive additional revenue and improved margins.
https://www.reportscorner.com/reports/15019/Mobile-VAS-Markets,-Applications,-and-Opportunities---Third-Edition/
The report provides a review and understanding of mergers and acquisitions (MandAs), capital-raising, partnering deals, and agreements entered into by defense companies during 2012.
Reports Corner added several new reports on the future of various packaging markets in Ukraine and Greece to 2017. The reports provide extensive time series consumption data on primary and outer packaging, covering materials, types, closures, and other segmentations. Tables and charts breakdown packaging usage to reveal market trends, dynamics, and growth areas.
Reports Corner has added a report on end-to-end machine-to-machine (M2M) communications to its offerings. The report provides an analysis of the emerging M2M technology and industry, including M2M applications, components, connectivity methods, strategies for mobile operators, and global market forecasts through 2020. It examines M2M uses across various industry verticals and technologies like cloud computing, sensors, and wireless protocols. The report aims to help businesses understand opportunities in the growing M2M sector.
Reports Corner provides research reports covering various sectors such as business, banking, healthcare, metals, natural resources, public sector, telecommunications, and transport. It partners with research organizations to deliver mandated research services to clients. Reports Corner aims to be a comprehensive source of reports across multiple industries.
PGx Analysis in VarSeq: A User’s PerspectiveGolden Helix
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
Dr. Tan's Balance Method.pdf (From Academy of Oriental Medicine at Austin)GeorgeKieling1
Home
Organization
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
About AOMA: The Academy of Oriental Medicine at Austin offers a masters-level graduate program in acupuncture and Oriental medicine, preparing its students for careers as skilled, professional practitioners. AOMA is known for its internationally recognized faculty, award-winning student clinical internship program, and herbal medicine program. Since its founding in 1993, AOMA has grown rapidly in size and reputation, drawing students from around the nation and faculty from around the world. AOMA also conducts more than 20,000 patient visits annually in its student and professional clinics. AOMA collaborates with Western healthcare institutions including the Seton Family of Hospitals, and gives back to the community through partnerships with nonprofit organizations and by providing free and reduced price treatments to people who cannot afford them. The Academy of Oriental Medicine at Austin is located at 2700 West Anderson Lane. AOMA also serves patients and retail customers at its south Austin location, 4701 West Gate Blvd. For more information see www.aoma.edu or call 512-492-303434.
The biomechanics of running involves the study of the mechanical principles underlying running movements. It includes the analysis of the running gait cycle, which consists of the stance phase (foot contact to push-off) and the swing phase (foot lift-off to next contact). Key aspects include kinematics (joint angles and movements, stride length and frequency) and kinetics (forces involved in running, including ground reaction and muscle forces). Understanding these factors helps in improving running performance, optimizing technique, and preventing injuries.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Pictorial and detailed description of patellar instability with sign and symptoms and how to diagnose , what investigations you should go with and how to approach with treatment options . I have presented this slide in my 2nd year junior residency in orthopedics at LLRM medical college Meerut and got good reviews for it
After getting it read you will definitely understand the topic.
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7shruti jagirdar
Unit 4: MRA 103T Regulatory affairs
This guideline is directed principally toward new Molecular Entities that are
likely to have significant use in the elderly, either because the disease intended
to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or
because the population to be treated is known to include substantial numbers of
geriatric patients (e.g., hypertension).
Introduction
Textile Mills in India industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and
forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within
the market. Essential resource for top-line data and analysis covering the India textile mills market. Includes market size and segmentation data, textual
and graphical analysis of market growth trends, leading companies and macroeconomic information.
https://www.reportscorner.com/reports/23018/Textile-Mills-in-India/
This document describes 11 reports available for purchase from ReportsCorner.com on topics including ICT spending predictions for industries in Belgium, the chocolate market in Asia-Pacific and BRIC countries, the gum market in BRIC countries, and the sugar confectionery market in BRIC countries. Each report costs $495-$1000 and provides historical and forecast data on consumption trends segmented by brand, channel, category and geography.
Immunoglobulins market to 2019 demand in primary immunodeficiency (pi) and ...Reports Corner
GBI Research's report "Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer's Disease" provides in-depth analysis of the global immunoglobulin market. The report analyzes the markets for immunoglobulin products in the US, the top five European countries (the UK, Germany, France, Italy and Spain) and Japan.
https://www.reportscorner.com/reports/20855/Immunoglobulins-Market-to-2019---Demand-in-Primary-Immunodeficiency-(PI)-and-Chronic-Inflammatory-Demyelinating-Polyneuropathy-(CIDP)-Potentially-Supplemented-by-Approvals-for-Alzheimers-Disease/
Next generation network oss bss market and forecast 2013-2018 - Reports CornerReports Corner
"NGN promises a high quality end-user experience. Telecommunications service providers expect the NGN framework to provide them with tools that would ensure customer loyalty. However, the path towards achieving the ideal NGN is fraught with formidable challenges. The most critical challenge confronting operators is optimizing their OSS and BSS platforms, systems, and processes.
With research beginning in 2007, the report Next Generation Network OSS/BSS Market and Forecast 2013-2018 provides a comprehensive analysis of drivers and issues related to technical and business aspects of OSS/BSS deployments and developments while forecasting their growth over the next five years."
https://www.reportscorner.com/reports/20852/Next-Generation-Network-OSS/BSS-Market-and-Forecast-2013-2018/
The cbrn defense market 2013 2023 - Reports CornerReports Corner
The document provides an overview and analysis of the global CBRN (chemical, biological, radiological, nuclear) defense market from 2013 to 2023. It finds that the market is expected to grow from $9 billion in 2013 to $13.7 billion in 2023, driven by threats from terrorism and hostile countries. North America currently leads the market but Asia-Pacific is expected to see the fastest growth. CBRN protection equipment accounts for the majority of the market currently but detection systems are expected to see increased investment over the forecast period. Key countries and their projected defense spending on CBRN capabilities are also analyzed.
Indian in vitro diagnostics market opportunity analysis 2018 - Reports CornerReports Corner
The Indian in vitro diagnostics (IVD) market is valued at over $500 million in 2018 and is expected to reach $1 billion by 2026, growing at a compound annual growth rate of 19%. This remarkable growth can be attributed to increased healthcare awareness, a desire for preventive health checkups, the availability of disease-specific tests, and a shift from manual to more automated equipment. The market is led by global players and lacks local manufacturers who can develop their own products and technologies. The report analyzes the segments of the Indian IVD market and identifies drivers of growth as well as challenges that must be addressed for continued expansion.
Pharmaceutical market india a comprehensive industry analysis - Reports CornerReports Corner
"1.0 Summary
“Pharmaceutical Market: India, A Competitive Industry Analysis” by Kelly Scientific Publications is a comprehensive report on the pharmaceutical and biotechnology industry in India and its impact on international markets. This report scrutinises top Indian pharmacos and their battle within domestic and international therapeutic markets. The business environment in which they compete is analysed as are key drivers, constraints, challenges and opportunities.
The Indian pharmaceutical market is set to become the eight largest pharma market globally by 2015. In 2012 it was worth $13 billion. It is forecast to reach $50 billion by 2015 and increase its dominance as a leading player in Asia. It is predicted that the Indian pharma market will be a significant global competitor by 2020 with an expected worth of up to $74 billion.
This report describes the current therapeutics that are propelling the biopharmaceutical market in India. It examines the current economic climate and how India compares to other emerging markets and also evolved markets such as the US and Europe. Current developments relating to patent expirations, government funding, and regulations are discussed. The emerging trends that appear in key sub-markets such as generics, oncology, cardiovascular, diabetes and vaccines are elucidated and analysed.
This study reveals market figures of the overall Indian pharmaceutical market and sub-markets. Forecast projections and future growth rates are provided to give the reader a forthcoming perspective of this growing industry.
https://www.reportscorner.com/reports/15826/Pharmaceutical-Market:-India-A-Comprehensive-Industry-Analysis/
Global pharmaceutical & biotechnology outlook 2013 japan pharma - Reports CornerReports Corner
The coming years will see Japan pharma regaining its status as innovator driven with Edoxaban for Daiichi Sankyo, Canagliflozin for Mitsubishi Tanabe, and Dolutegravir for Shionogi bringing the good times back for the respective companies in 2013 and carrying enough potential to change global market dynamics in the anticoagulant, diabetes and HIV space resp. We think that the massive ~$45b poured in acquiring innovation by Japanese companies does not justify its value as we find that the key catalysts from Japan are in-house candidates.
https://www.reportscorner.com/reports/10015/Global-Pharmaceutical-&-Biotechnology-Outlook-2013:-Japan-Pharma/
Global pharmaceutical & biotechnology outlook 2013 rising stars - Reports CornerReports Corner
Innovative and improved drugs therapies developed through novel target discovery and technology platforms have originated from the backyards of small research focused companies (Rising Stars, RS, non-profitable biotech companies). The universe continues to grow despite the high risk and the wait to transform into a successful profitable Mature Biotech is long.
https://www.reportscorner.com/reports/10016/Global-Pharmaceutical-&-Biotechnology-Outlook-2013:-Rising-Stars/
Mobile vas markets, applications, and opportunities third edition - Reports...Reports Corner
Mobile Value-added Service (VAS) applications represent a key aspect to the ongoing success of mobile network operators and everyone in the mobile communications value chain. With core services, such as bear voice and data communications becoming commodity offerings, wireless service providers are dependent on VAS applications to drive additional revenue and improved margins.
https://www.reportscorner.com/reports/15019/Mobile-VAS-Markets,-Applications,-and-Opportunities---Third-Edition/
The report provides a review and understanding of mergers and acquisitions (MandAs), capital-raising, partnering deals, and agreements entered into by defense companies during 2012.
Reports Corner added several new reports on the future of various packaging markets in Ukraine and Greece to 2017. The reports provide extensive time series consumption data on primary and outer packaging, covering materials, types, closures, and other segmentations. Tables and charts breakdown packaging usage to reveal market trends, dynamics, and growth areas.
Reports Corner has added a report on end-to-end machine-to-machine (M2M) communications to its offerings. The report provides an analysis of the emerging M2M technology and industry, including M2M applications, components, connectivity methods, strategies for mobile operators, and global market forecasts through 2020. It examines M2M uses across various industry verticals and technologies like cloud computing, sensors, and wireless protocols. The report aims to help businesses understand opportunities in the growing M2M sector.
Reports Corner provides research reports covering various sectors such as business, banking, healthcare, metals, natural resources, public sector, telecommunications, and transport. It partners with research organizations to deliver mandated research services to clients. Reports Corner aims to be a comprehensive source of reports across multiple industries.
PGx Analysis in VarSeq: A User’s PerspectiveGolden Helix
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
Dr. Tan's Balance Method.pdf (From Academy of Oriental Medicine at Austin)GeorgeKieling1
Home
Organization
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
About AOMA: The Academy of Oriental Medicine at Austin offers a masters-level graduate program in acupuncture and Oriental medicine, preparing its students for careers as skilled, professional practitioners. AOMA is known for its internationally recognized faculty, award-winning student clinical internship program, and herbal medicine program. Since its founding in 1993, AOMA has grown rapidly in size and reputation, drawing students from around the nation and faculty from around the world. AOMA also conducts more than 20,000 patient visits annually in its student and professional clinics. AOMA collaborates with Western healthcare institutions including the Seton Family of Hospitals, and gives back to the community through partnerships with nonprofit organizations and by providing free and reduced price treatments to people who cannot afford them. The Academy of Oriental Medicine at Austin is located at 2700 West Anderson Lane. AOMA also serves patients and retail customers at its south Austin location, 4701 West Gate Blvd. For more information see www.aoma.edu or call 512-492-303434.
The biomechanics of running involves the study of the mechanical principles underlying running movements. It includes the analysis of the running gait cycle, which consists of the stance phase (foot contact to push-off) and the swing phase (foot lift-off to next contact). Key aspects include kinematics (joint angles and movements, stride length and frequency) and kinetics (forces involved in running, including ground reaction and muscle forces). Understanding these factors helps in improving running performance, optimizing technique, and preventing injuries.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Pictorial and detailed description of patellar instability with sign and symptoms and how to diagnose , what investigations you should go with and how to approach with treatment options . I have presented this slide in my 2nd year junior residency in orthopedics at LLRM medical college Meerut and got good reviews for it
After getting it read you will definitely understand the topic.
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7shruti jagirdar
Unit 4: MRA 103T Regulatory affairs
This guideline is directed principally toward new Molecular Entities that are
likely to have significant use in the elderly, either because the disease intended
to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or
because the population to be treated is known to include substantial numbers of
geriatric patients (e.g., hypertension).
The Children are very vulnerable to get affected with respiratory disease.
In our country, the respiratory Disease conditions are consider as major cause for mortality and Morbidity in Child.
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...Donc Test
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
- Video recording of this lecture in English language: https://youtu.be/RvdYsTzgQq8
- Video recording of this lecture in Arabic language: https://youtu.be/ECILGWtgZko
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Congestive Heart failure is caused by low cardiac output and high sympathetic discharge. Diuretics reduce preload, ACE inhibitors lower afterload, beta blockers reduce sympathetic activity, and digitalis has inotropic effects. Newer medications target vasodilation and myosin activation to improve heart efficiency while lowering energy requirements. Combination therapy, following an assessment of cardiac function and volume status, is the most effective strategy to heart failure care.
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
2. Description
"Product Synopsis:The Future of the Prepared Meals Market in
Hong Kong to 2017 is the result of Canadean's extensive market
research. The report presents detailed analysis on the Prepared
Meals consumption trends in Hong Kong, historic and forecast
Prepared Meals consumption volumes and values at market and
category level, brand share and distribution channel data."
www.reportscorner.com Reports Corner
3. Brief Summary
Product Synopsis:
The Future of the Prepared Meals Market in Hong Kong to 2017 is
the result of Canadean's extensive market research. The report
presents detailed analysis on the Prepared Meals consumption
trends in Hong Kong, historic and forecast Prepared Meals
consumption volumes and values at market and category level,
brand share and distribution channel data. This report brings
together Canadean Intelligence's research, modeling and analysis
expertise in order to develop uniquely detailed market data.
This allows domestic and foreign companies to identify the
market dynamics to account for Prepared Meals sales overall and
to know which categories and segments are showing growth in
the coming years.
www.reportscorner.com Reports Corner
4. Brief Summary
Introduction and Landscape
Why was the report written?
- This report provides authoritative and granular data on the
Prepared Meals market in Hong Kong and, in doing so fills the
gaps in marketers' understanding of trends and the components
of change behind them.
- Based upon extensive primary and secondary research to
provide comprehensive and granular data, this report allows
marketers to confidently update their strategic and tactical plans.
- Marketers need data on volume and value changes, brand
dynamics and distribution trends in order to effectively plan
strategies.
www.reportscorner.com Reports Corner
5. Brief Summary
What are the key drivers behind recent market changes?
This report examines the components of change in the market by
looking at historic and future growth patterns, including the
effects of consumers' behavior on total volumes, values, brands
selected and types of product chosen.
What makes this report unique and essential to read?
The report provides the latest, detailed data on dynamics in Hong
Kong Prepared Meals market, providing marketers with the
essential data to understand their own, and their competitors'
position in the market and the information to accurately identify
where to compete in the future.
Key Features and Benefits
Detailed category coverage is provided, covering three product
segments that include: Meal Kits, Pizza, Ready Meals.
www.reportscorner.com Reports Corner
6. Brief Summary
Detailed product sales segmentation (for both volumes and
values) is provided, including brand data, and sales by
distribution channel, at the product category level.
Future forecasts allow marketers to understand the future pattern
of market trends from winners and losers to category dynamics
and thereby quickly and easily identify the key areas in which they
want to compete in the future.
www.reportscorner.com Reports Corner
7. Table of Contents
1 Introduction
1.1 What is this Report About?
1.2 Definitions
1.2.1 This report provides 2012 actual sales; while forecasts are provided for 2013 - 2017.
1.2.2 Category Definitions
1.2.3 Distribution Channel Definitions
1.2.4 Volume Units and Aggregations
1.2.5 CAGR Definition and Calculation
1.2.6 Graphical representation of Brands
1.2.7 Exchange Rates
1.2.8 Methodology Summary
2 Hong Kong Prepared Meals Market Analysis, 2007-17
2.1 Prepared Meals Value Analysis, 2007-17
2.1.1 Overall Prepared Meals Market Value, 2007-17
www.reportscorner.com Reports Corner
8. Table of Contents
2.1.2 Prepared Meals Market Value by Category, 2007-17
2.1.3 Market Growth Dynamics by Value - Prepared Meals, 2007-17
2.2 Prepared Meals Volume Analysis, 2007-17
2.2.1 Overall Prepared Meals Market Volume, 2007-17
2.2.2 Per-Capita Consumption - Prepared Meals, 2007-17
2.2.3 Prepared Meals Market Volume by Category, 2007-17
2.2.4 Market Growth Dynamics by Volume - Prepared Meals, 2007-17
3 Hong Kong Meal Kits Market Analysis, 2007-17
3.1 Meal Kits Value Analysis, 2007-17
3.1.1 Meal Kits Market by Value, 2007-17
3.1.2 Average Consumer Price/Kg - Meal Kits, 2007-17
3.1.3 Meal Kits Market Value by Segments, 2007-17
3.2 Meal Kits Volume Analysis, 2007-17
3.2.1 Meal Kits Market by Volume, 2007-17
www.reportscorner.com Reports Corner
13. Table of Contents
5.7.1 Frozen Ready Meals Market by Value, 2007-17
5.7.2 Frozen Ready Meals Market by Volume, 2007-17
5.8 Ready Meals Brand Analysis, 2009-12
5.9 Ready Meals Distribution Channel Analysis, 2009-12
6 Appendix
6.1 About Canadean
6.2 Disclaimer
www.reportscorner.com Reports Corner
14. For more information
For more information please visit our website
https://www.reportscorner.com/reports/14966/The-Future-of-the-Prepared-Meals-
Market-in-Hong-Kong-to-2017/
www.reportscorner.com Reports Corner
15. RC
Thank You
Contact us: contact@reportscorner.com
www.reportscorner.com Reports Corner